New Research Funding to Explore Innovative Approaches to Chronic Parkinson’s PainOctober 28, 2026Leave a commentRead article
New Research Validates LanCL1 as a Therapeutic Target in Neuropathic PainJune 11, 2026Leave a commentRead article
Lateral Pharma Featured in the Media: A New Approach to Respiratory DiseaseApril 10, 2026Leave a commentRead article
Lateral Pharma Awarded Second Place at International Pitch CompetitionMarch 1, 2026Leave a commentRead article
Lateral Pharma Secures U.S. Composition‑of‑Matter Patent for LAT9997 in Neuropathic PainFebruary 22, 2026Leave a commentRead article
Lateral Pharma and Hudson Institute Publish New Research on Preventing Post-Influenza PneumoniaFebruary 11, 2026Leave a commentRead article
Lateral Pharma Compounds Demonstrate Neuroprotective Properties in Alzheimers Mini-Brain ModelApril 4, 2025Read article
Lateral Pharma Awarded Support via Victorian Medical Research Acceleration FundMay 9, 2023Leave a commentRead article
Lateral Pharma’s Novel Therapy Shows Promise for Severe InfluenzaApril 5, 2023Leave a commentRead article
Lateral Pharma Presents Findings at the Australian Pain Society ConferenceApril 3, 2023Leave a commentRead article
Lateral Pharma Promotes Two Members of its Team to Senior PositionsFebruary 14, 2023Leave a commentRead article
Lateral Pharma Appoints Scientific Affairs Manager – Dr Lauren ElyMay 9, 2022Leave a commentRead article
